Financial Statements for Human Genome Sciences

Search Images Maps Play YouTube News Gmail Drive More »

Help | Sign in

Recent Quotes (30 days)

You have no recent quotes

chg | %

Human Genome Sciences financials

Watch this stock

Income Statement

Balance Sheet

Cash Flow

View: Quarterly Data | Annual Data

Hide charts

In Millions of USD (except for per share items)	3 months ending 2012-06-30	3 months ending 2012-03-31	3 months ending 2011-12-31	3 months ending 2011-09-30	3 months ending 2011-06-30
Revenue	60.34	47.13	45.52	34.02	24.86
Other Revenue, Total	-	-	-	-	-
Total Revenue	60.34	47.13	45.52	34.02	24.86
Cost of Revenue, Total	29.66	27.78	18.74	17.37	18.35
Gross Profit	30.69	19.35	26.78	16.65	6.51
Selling/General/Admin. Expenses, Total	51.23	40.29	42.09	42.13	39.44
Research & Development	35.44	39.57	39.54	38.76	33.40
Depreciation/Amortization	-	-	-	-	-
Interest Expense(Income) - Net Operating	-	-	-	-	-
Unusual Expense (Income)	0.00	0.00	0.00	0.00	0.00
Other Operating Expenses, Total	19.20	15.68	14.22	11.76	2.16
Total Operating Expense	135.53	123.31	114.58	110.02	93.35
Operating Income	-75.19	-76.18	-69.06	-76.00	-68.49
Interest Income(Expense), Net Non-Operating	-	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-
Other, Net	0.10	0.07	1.38	-0.44	0.36
Income Before Tax	-92.80	-93.50	-81.02	-88.43	-80.66
Income After Tax	-92.80	-93.50	-81.02	-88.43	-80.66
Minority Interest	-	-	-	-	-
Equity In Affiliates	-	-	-	-	-
Net Income Before Extra. Items	-92.80	-93.50	-81.02	-88.43	-80.66
Accounting Change	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Extraordinary Item	-	-	-	-	-
Net Income	-92.80	-93.50	-81.02	-88.43	-80.66
Preferred Dividends	-	-	-	-	-
Income Available to Common Excl. Extra Items	-92.80	-93.50	-81.02	-88.43	-80.66
Income Available to Common Incl. Extra Items	-92.80	-93.50	-81.02	-88.43	-80.66
Basic Weighted Average Shares	-	-	-	-	-
Basic EPS Excluding Extraordinary Items	-	-	-	-	-
Basic EPS Including Extraordinary Items	-	-	-	-	-
Dilution Adjustment	0.00	0.00	0.00	0.00	0.00
Diluted Weighted Average Shares	199.59	198.97	198.71	196.46	190.28
Diluted EPS Excluding Extraordinary Items	-0.46	-0.47	-0.41	-0.45	-0.42
Diluted EPS Including Extraordinary Items	-	-	-	-	-
Dividends per Share - Common Stock Primary Issue	0.00	0.00	0.00	0.00	0.00
Gross Dividends - Common Stock	-	-	-	-	-
Net Income after Stock Based Comp. Expense	-	-	-	-	-
Basic EPS after Stock Based Comp. Expense	-	-	-	-	-
Diluted EPS after Stock Based Comp. Expense	-	-	-	-	-
Depreciation, Supplemental	-	-	-	-	-
Total Special Items	-	-	-	-	-
Normalized Income Before Taxes	-	-	-	-	-
Effect of Special Items on Income Taxes	-	-	-	-	-
Income Taxes Ex. Impact of Special Items	-	-	-	-	-
Normalized Income After Taxes	-	-	-	-	-
Normalized Income Avail to Common	-	-	-	-	-
Basic Normalized EPS	-	-	-	-	-
Diluted Normalized EPS	-0.46	-0.47	-0.41	-0.45	-0.42

In Millions of USD (except for per share items)	12 months ending 2011-12-31	12 months ending 2010-12-31	12 months ending 2009-12-31	12 months ending 2008-12-31
Revenue	130.97	157.35	275.75	48.42
Other Revenue, Total	-	-	-	-
Total Revenue	130.97	157.35	275.75	48.42
Cost of Revenue, Total	76.06	44.96	34.02	0.00
Gross Profit	54.91	112.39	241.73	48.42
Selling/General/Admin. Expenses, Total	158.78	106.80	61.07	60.87
Research & Development	196.18	196.37	173.71	243.26
Depreciation/Amortization	-	-	-	-
Interest Expense(Income) - Net Operating	-	-	-	-
Unusual Expense (Income)	-1.72	0.00	-38.11	0.00
Other Operating Expenses, Total	31.22	0.00	0.00	-
Total Operating Expense	460.53	348.12	230.69	304.12
Operating Income	-329.55	-190.77	45.06	-255.70
Interest Income(Expense), Net Non-Operating	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-
Other, Net	-1.67	0.08	-0.24	-6.28
Income Before Tax	-381.11	-233.23	4.38	-268.89
Income After Tax	-381.11	-233.23	5.66	-268.89
Minority Interest	-	-	-	-
Equity In Affiliates	-	-	-	-
Net Income Before Extra. Items	-381.11	-233.23	5.66	-268.89
Accounting Change	-	-	-	-
Discontinued Operations	-	-	-	-
Extraordinary Item	-	-	-	-
Net Income	-381.11	-233.23	5.66	-268.89
Preferred Dividends	-	-	-	-
Income Available to Common Excl. Extra Items	-381.11	-233.23	5.66	-268.89
Income Available to Common Incl. Extra Items	-381.11	-233.23	5.66	-268.89
Basic Weighted Average Shares	-	-	-	-
Basic EPS Excluding Extraordinary Items	-	-	-	-
Basic EPS Including Extraordinary Items	-	-	-	-
Dilution Adjustment	0.00	0.00	0.00	0.00
Diluted Weighted Average Shares	193.67	187.79	155.05	135.41
Diluted EPS Excluding Extraordinary Items	-1.97	-1.24	0.04	-1.99
Diluted EPS Including Extraordinary Items	-	-	-	-
Dividends per Share - Common Stock Primary Issue	0.00	0.00	0.00	0.00
Gross Dividends - Common Stock	-	-	-	-
Net Income after Stock Based Comp. Expense	-	-	-	-
Basic EPS after Stock Based Comp. Expense	-	-	-	-
Diluted EPS after Stock Based Comp. Expense	-	-	-	-
Depreciation, Supplemental	-	-	-	-
Total Special Items	-	-	-	-
Normalized Income Before Taxes	-	-	-	-
Effect of Special Items on Income Taxes	-	-	-	-
Income Taxes Ex. Impact of Special Items	-	-	-	-
Normalized Income After Taxes	-	-	-	-
Normalized Income Avail to Common	-	-	-	-
Basic Normalized EPS	-	-	-	-
Diluted Normalized EPS	-1.98	-1.24	-0.12	-1.99

In Millions of USD (except for per share items)	As of 2012-06-30	As of 2012-03-31	As of 2011-12-31	As of 2011-09-30	As of 2011-06-30
Cash & Equivalents	349.96	349.22	402.05	37.66	53.69
Short Term Investments	120.21	122.58	119.23	502.14	139.88
Cash and Short Term Investments	470.17	471.80	521.28	539.80	193.57
Accounts Receivable - Trade, Net	58.33	72.49	54.76	44.44	38.34
Receivables - Other	-	-	-	-	-
Total Receivables, Net	90.73	89.94	77.77	61.98	69.81
Total Inventory	22.76	45.04	41.66	40.24	38.85
Prepaid Expenses	10.50	8.91	9.39	13.96	5.58
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	594.16	615.69	650.10	655.98	307.80
Property/Plant/Equipment, Total - Gross	-	-	-	-	-
Accumulated Depreciation, Total	-	-	-	-	-
Goodwill, Net	-	-	-	-	-
Intangibles, Net	-	-	-	-	-
Long Term Investments	204.19	247.38	279.96	0.00	429.71
Other Long Term Assets, Total	226.54	203.51	203.86	166.63	142.32
Total Assets	1,275.65	1,328.17	1,407.58	1,097.28	1,148.45
Accounts Payable	-	-	-	-	-
Accrued Expenses	29.21	19.83	34.34	28.84	26.51
Notes Payable/Short Term Debt	0.00	0.00	0.00	0.00	0.00
Current Port. of LT Debt/Capital Leases	205.46	201.70	198.04	272.80	193.21
Other Current liabilities, Total	10.66	7.84	10.49	8.68	6.82
Total Current Liabilities	331.73	312.55	323.55	384.48	288.21
Long Term Debt	371.02	367.33	363.70	0.00	190.97
Capital Lease Obligations	252.81	252.48	252.10	251.74	251.39
Total Long Term Debt	623.84	619.81	615.80	251.74	442.36
Total Debt	829.29	821.50	813.84	524.55	635.57
Deferred Income Tax	-	-	-	-	-
Minority Interest	-	-	-	-	-
Other Liabilities, Total	19.44	19.14	11.80	12.26	12.43
Total Liabilities	975.00	951.50	951.16	648.48	743.00
Redeemable Preferred Stock, Total	-	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-	-
Common Stock, Total	2.00	1.99	1.99	1.99	1.91
Additional Paid-In Capital	3,280.31	3,262.92	3,250.88	3,161.19	3,028.97
Retained Earnings (Accumulated Deficit)	-2,987.30	-2,894.50	-2,801.00	-2,719.98	-2,631.55
Treasury Stock - Common	-	-	-	-	-
Other Equity, Total	5.64	6.26	4.56	5.60	6.13
Total Equity	300.65	376.67	456.42	448.80	405.45
Total Liabilities & Shareholders' Equity	1,275.65	1,328.17	1,407.58	1,097.28	1,148.45
Shares Outs - Common Stock Primary Issue	-	-	-	-	-
Total Common Shares Outstanding	199.99	199.07	198.75	198.66	190.67

In Millions of USD (except for per share items)	As of 2011-12-31	As of 2010-12-31	As of 2009-12-31	As of 2008-12-31
Cash & Equivalents	402.05	155.69	567.67	15.25
Short Term Investments	119.23	282.02	151.53	22.69
Cash and Short Term Investments	521.28	437.71	719.20	37.94
Accounts Receivable - Trade, Net	54.76	25.96	23.89	2.87
Receivables - Other	-	-	-	-
Total Receivables, Net	77.77	44.81	34.25	24.95
Total Inventory	41.66	43.09	20.15	0.00
Prepaid Expenses	9.39	5.57	7.18	5.28
Other Current Assets, Total	-	-	-	-
Total Current Assets	650.10	531.18	780.77	68.17
Property/Plant/Equipment, Total - Gross	426.19	409.75	403.25	392.88
Accumulated Depreciation, Total	-175.17	-156.62	-140.13	-118.56
Goodwill, Net	-	-	-	-
Intangibles, Net	-	-	-	-
Long Term Investments	279.96	416.17	387.04	268.25
Other Long Term Assets, Total	203.86	85.34	92.78	76.11
Total Assets	1,407.58	1,315.03	1,530.63	686.83
Accounts Payable	-	-	-	-
Accrued Expenses	34.34	31.39	33.22	21.53
Notes Payable/Short Term Debt	0.00	0.00	0.00	0.00
Current Port. of LT Debt/Capital Leases	198.04	188.62	0.00	-
Other Current liabilities, Total	10.49	6.15	88.56	43.75
Total Current Liabilities	323.55	280.94	164.16	120.71
Long Term Debt	363.70	184.23	349.81	417.60
Capital Lease Obligations	252.10	250.52	248.63	246.48
Total Long Term Debt	615.80	434.75	598.43	664.07
Total Debt	813.84	623.37	598.43	664.07
Deferred Income Tax	-	-	-	-
Minority Interest	-	-	-	-
Other Liabilities, Total	11.80	13.57	12.62	38.36
Total Liabilities	951.16	729.27	775.22	823.14
Redeemable Preferred Stock, Total	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-
Common Stock, Total	1.99	1.89	1.85	1.36
Additional Paid-In Capital	3,250.88	2,996.64	2,932.86	2,059.15
Retained Earnings (Accumulated Deficit)	-2,801.00	-2,419.90	-2,186.67	-2,192.32
Treasury Stock - Common	-	-	-	-
Other Equity, Total	4.56	7.12	7.37	-4.49
Total Equity	456.42	585.76	755.41	-136.30
Total Liabilities & Shareholders' Equity	1,407.58	1,315.03	1,530.63	686.83
Shares Outs - Common Stock Primary Issue	-	-	-	-
Total Common Shares Outstanding	198.75	188.98	185.25	135.74

In Millions of USD (except for per share items)	6 months ending 2012-06-30	3 months ending 2012-03-31	12 months ending 2011-12-31	9 months ending 2011-09-30
Net Income/Starting Line	-186.30	-93.50	-381.11	-300.08
Depreciation/Depletion	12.24	6.16	21.69	16.09
Amortization	-	-	-	-
Deferred Taxes	-	-	-	-
Non-Cash Items	37.55	18.78	63.82	44.43
Changes in Working Capital	5.98	-14.46	-102.32	-76.27
Cash from Operating Activities	-130.52	-83.02	-397.92	-315.84
Capital Expenditures	-5.25	-2.21	-18.99	-11.49
Other Investing Cash Flow Items, Total	76.87	31.65	296.33	193.34
Cash from Investing Activities	71.62	29.45	277.34	181.85
Financing Cash Flow Items	-0.68	-0.35	-66.56	-0.92
Total Cash Dividends Paid	-	-	-	-
Issuance (Retirement) of Stock, Net	7.48	1.10	17.34	16.87
Issuance (Retirement) of Debt, Net	-	-	416.15	-
Cash from Financing Activities	6.81	0.74	366.94	15.96
Foreign Exchange Effects	-	-	-	-
Net Change in Cash	-52.09	-52.83	246.36	-118.03
Cash Interest Paid, Supplemental	22.63	8.58	32.55	25.41
Cash Taxes Paid, Supplemental	-	0.00	0.00	0.00

In Millions of USD (except for per share items)	12 months ending 2011-12-31	12 months ending 2010-12-31	12 months ending 2009-12-31	12 months ending 2008-12-31
Net Income/Starting Line	-381.11	-233.23	5.66	-268.89
Depreciation/Depletion	21.69	21.30	21.25	21.14
Amortization	-	-	-	-
Deferred Taxes	-	-	-	-
Non-Cash Items	63.82	50.66	-5.15	18.52
Changes in Working Capital	-102.32	-119.42	-22.09	-31.04
Cash from Operating Activities	-397.92	-280.69	-0.33	-260.26
Capital Expenditures	-18.99	-9.78	-10.02	-9.72
Other Investing Cash Flow Items, Total	296.33	-158.16	-228.21	248.87
Cash from Investing Activities	277.34	-167.94	-238.23	239.15
Financing Cash Flow Items	-66.56	-1.59	-20.58	-2.78
Total Cash Dividends Paid	-	-	-	-
Issuance (Retirement) of Stock, Net	17.34	38.24	861.56	4.33
Issuance (Retirement) of Debt, Net	416.15	0.00	-50.00	0.00
Cash from Financing Activities	366.94	36.65	790.98	1.55
Foreign Exchange Effects	-	-	-	-
Net Change in Cash	246.36	-411.98	552.42	-19.57
Cash Interest Paid, Supplemental	32.55	33.17	33.61	34.73
Cash Taxes Paid, Supplemental	0.00	-1.95	0.81	0.00